Merck reports 39% fall in Q3 net profit

24 Oct 2013 Evaluate

Merck has reported results for the third quarter ended September 30, 2013.

The company has reported 38.88% fall in its net profit at Rs 15.77 crore for the quarter as compared to Rs 25.80 crore for the same quarter in the previous year. However, total income from operations of the company has increased by 10.39% at Rs 207.47 crore for quarter under review as compared to Rs 187.95 crore for the quarter ended September 30, 2012.

Merck is a global pharmaceutical and chemical enterprise. In the pharmaceutical segment major products include vitamins, nutritional supplement, cardio vascular, respiratory, hematinics, cough and cold, non-steroidal anti-inflammatory (NSAID), antibiotics, oral rehydration salts and encephalotropics.

Procter&Gamble Healt Share Price

5450.35 -54.55 (-0.99%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.